Medicare Enrolled

Dr. Sunil Patel, M.D.

Internal Medicine · Texarkana, TX
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Low-engagement
2602 SAINT MICHAEL DR STE 202, Texarkana, TX 75503
9036145480
In practice since 2007 (19 years)
NPI: 1588715916 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Patel from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Patel? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Patel

Dr. Sunil Patel is an internal medicine specialist in Texarkana, TX, with 19 years of NPI registration. Based on federal Medicare data, Dr. Patel performed 1,411 Medicare services across 856 unique beneficiaries.

Between the years covered by Open Payments, Dr. Patel received a total of $14,389 from 98 pharmaceutical and/or device companies across 814 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in internal medicine. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Patel is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years in practice ▲ Top 26% volume in TX $14,389 industry payments

Medicare Practice Summary

Medicare Utilization ↗
1,411
Medicare services
Top 26% in TX for internal medicine
856
Unique beneficiaries
$71
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~74 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Office visit, established patient (30-39 min) 794 $73 $242
Office visit, established patient (20-29 min) 336 $47 $162
Office visit, established patient, complex (40-54 min) 81 $109 $343
New patient office visit (45-59 min) 40 $104 $326
Hospital follow-up visit, moderate complexity 40 $62 $154
New patient office visit, complex (60-74 min) 35 $132 $395
New patient office visit (30-44 min) 28 $60 $196
Initial hospital admission, moderate complexity 26 $102 $289
Biopsy and aspiration of bone marrow sample for diagnosis 17 $59 $475
Initial hospital admission, high complexity 14 $136 $418
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$14,389
Total received (2018-2024)
Avg $2,056/year across 7 years
Top 6% in TX for internal medicine
98
Companies
814
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$13,662 (94.9%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$727 (5.1%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$1,804
2023
$2,116
2022
$2,299
2021
$1,357
2020
$1,579
2019
$2,503
2018
$2,730

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Novartis Pharmaceuticals Corporation
$1,033
Amgen Inc.
$1,030
PFIZER INC.
$1,003
Merck Sharp & Dohme Corporation
$661
AstraZeneca Pharmaceuticals LP
$622
Coherus Biosciences Inc.
$617
Janssen Biotech, Inc.
$606
Incyte Corporation
$518
E.R. Squibb & Sons, L.L.C.
$511
Genentech USA, Inc.
$421
Celgene Corporation
$378
Takeda Pharmaceuticals U.S.A., Inc.
$344
GENZYME CORPORATION
$304
Lilly USA, LLC
$298
Exelixis Inc.
$274
EMD Serono, Inc.
$267
Boehringer Ingelheim Pharmaceuticals, Inc.
$230
Bayer HealthCare Pharmaceuticals Inc.
$228
GlaxoSmithKline, LLC.
$226
Seagen Inc.
$217
Gilead Sciences, Inc.
$214
AbbVie Inc.
$210
Astellas Pharma US Inc
$198
Merck Sharp & Dohme LLC
$158
TerSera Therapeutics LLC
$147
Sirtex Medical Inc
$146
Janssen Pharmaceuticals, Inc
$139
ABBVIE INC.
$127
Ipsen Biopharmaceuticals, Inc
$114
Rigel Pharmaceuticals, Inc.
$114
Genmab U.S., Inc.
$113
Pharmacyclics LLC, An AbbVie Company
$112
EISAI INC.
$109
SOBI, INC
$109
Adaptive Biotechnologies Corporation
$99
Clovis Oncology, Inc.
$94
Sun Pharmaceutical Industries Inc.
$93
Bayer Healthcare Pharmaceuticals Inc.
$93
Karyopharm Therapeutics Inc.
$88
Taiho Oncology, Inc.
$80
Regeneron Healthcare Solutions, Inc.
$77
Pharmacyclics LLC, an AbbVie Company
$75
AbbVie, Inc.
$73
ADC Therapeutics America, Inc.
$72
PUMA BIOTECHNOLOGY, INC.
$68
Heron Therapeutics, Inc.
$68
Deciphera Pharmaceuticals Inc.
$60
Puma Biotechnology, Inc.
$60
BeiGene USA, Inc.
$58
Verastem, Inc.
$56
PharmaEssentia USA Corporation
$56
Eisai Inc.
$53
Daiichi Sankyo Inc.
$53
Dendreon Pharmaceuticals LLC
$53
Kyowa Kirin, Inc.
$51
Acrotech Biopharma LLC
$50
Teva Pharmaceuticals USA, Inc.
$45
TAIHO ONCOLOGY, INC.
$43
Mirati Therapeutics, Inc.
$41
AVEO Pharmaceuticals, Inc.
$38
CTI BioPharma Corp.
$36
Acceleron Pharma, Inc.
$35
Blueprint Medicines Corporation
$35
ARRAY BIOPHARMA INC
$34
Dova Pharmaceuticals
$34
Alexion Pharmaceuticals, Inc.
$32
Myriad Genetic Laboratories, Inc.
$31
Epizyme, Inc.,
$29
MEDIVATION FIELD SOLUTIONS LLC
$29
Janssen Scientific Affairs, LLC
$29
Stemline Therapeutics Inc.
$28
Pharmacosmos Therapeutics Inc.
$28
Alnylam Pharmaceuticals Inc.
$28
Roche Diagnostics Corporation
$26
Seattle Genetics, Inc.
$26
Kite Pharma, Inc.
$25
Jazz Pharmaceuticals Inc.
$25
Sobi, Inc
$25
AMAG Pharmaceuticals, Inc.
$24
ImmunoGen, Inc.
$24
MorphoSys, US Inc.
$23
Spectrum Pharmaceuticals Inc.
$23
Azurity Pharmaceuticals, Inc.
$21
JAZZ PHARMACEUTICALS INC.
$21
RECORDATI_RARE_DISEASES_INC.
$20
TESARO, Inc.
$19
Tempus AI, Inc
$19
Secura Bio, Inc.
$19
MACROGENICS, INC.
$18
Agios Pharmaceuticals, Inc.
$16
Lexicon Pharmaceuticals, Inc.
$16
G1 Therapeutics, Inc.
$16
Octapharma USA, Inc.
$15
MENARINI SILICON BIOSYSTEMS, INC.
$14
Fresenius Kabi USA, LLC
$14
Helsinn Therapeutics (U.S.), Inc.
$13
Foundation Medicine, Inc.
$13
Array BioPharma Inc.
$12
Top 3 companies account for 21.3% of total payments
Associated products mentioned in payments ›
ADCETRIS · AFINITOR · AKYNZEO · ALIMTA · ALPROLIX · ALUNBRIG · AYVAKIT · Abraxane · Adthyza · Alecensa · Aliqopa · Avastin · BAVENCIO · BELEODAQ · BENDEKA · BESREMI · BLENREP · BOSULIF · BRAFTOVI · BRUKINSA · BYNFEZIA PEN · Bavencio · Blincyto · Braftovi · CABLIVI · CABOMETYX · CALQUENCE · CARVYKTI · CINVANTI · COSELA · CYRAMZA · Cabometyx · Cellsearch · Columvi · Copiktra · DARZALEX · DOPTELET · Doptelet · ELAHERE · ELIQUIS · ELITEK · ELZONRIS · EMPLICITI · ENHERTU · ENJAYMO · EPKINLY · EVENITY · Elahere · Epkinly · Erleada · FARYDAK · FASLODEX · FERAHEME · FOTIVDA · FOUNDATIONONE · FRUZAQLA · GAZYVA · GILOTRIF · IBRANCE · ICLUSIG · IMBRUVICA · IMFINZI · IMJUDO · INJECTAFER · INLYTA · INQOVI · Imbruvica · Inrebic · JAKAFI · JEMPERLI · JEVTANA · KANJINTI · KEYTRUDA · KISQALI · KRAZATI · Kyprolis · LIBTAYO · LIBTAYO CEMIPLIMAB-RWLC INJECTION · LONSURF · LOQTORZI · LUMAKRAS · LYNPARZA · Lenvima · Lonsurf · Lunsumio · MARGENZA · MEKINIST · MONJUVI · MVASI · MYRISK · NERLYNX · NINLARO · Neulasta · Nplate · Nubeqa · OFEV · OJJAARA · ONUREG · OPDIVO · OPDUALAG · OXLUMO · Onivyde · PADCEV · PANZYGA · PEMAZYRE · PIQRAY · PLUVICTO · POTELIGEO · PROMACTA · PROVENGE · Padcev · Perjeta · Pomalyst · Poteligeo · QINLOCK · REBLOZYL · ROLVEDON · RYBREVANT · RYDAPT · Reblozyl · Revlimid · Rezlidhia · Rubraca · SARCLISA · SCEMBLIX · SHINGRIX · SIR-Spheres Microspheres · SOMATULINE DEPOT · SUSTOL · SUSVIMO · SUTENT · SYLVANT · Somatuline Depot · Stimufend · Stivarga · TAGRISSO · TASIGNA · TAZVERIK · TECENTRIQ · TECVAYLI · TIBSOVO · TIVDAK · TUKYSA · Tavalisse · Tecentriq · Tivdak · Trodelvy · ULTOMIRIS · Udenyca · Ultomiris · VARUBI · VENCLEXTA · VERZENIO · VONVENDI · VOTRIENT · VYXEOS · Venclexta · Vitrakvi · Vonjo · XALKORI · XARELTO · XGEVA · XPOVIO · XT CDX · XTANDI · Xermelo · Xofigo · Xtandi · YONSA · ZEJULA · ZOLADEX · ZYTIGA · clonoSEQ
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (95%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians. Total industry engagement is in the top 6% for internal medicine in TX.

Equivalent to $1,020 per 100 Medicare services performed
Looking for an internal medicine specialist in Texarkana?
Compare internal medicine physicians in the Texarkana area by procedure volume, costs, and industry payment transparency.
Browse internal medicine physicians nearby

Geographic Context

Internal medicine physicians within 10 mi
40
Per 100K population
43.3
County median income
$59,295
Nearest hospital
CHRISTUS ST MICHAEL HEALTH SYSTEM
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Patel is a clinical cardiology specialist, with above-average Medicare volume (top 26% in TX), with low-engagement industry engagement in the top 6% of TX peers, with 19 years of NPI registration.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Patel experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Patel performed 794 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Patel receive payments from pharmaceutical companies?
Yes. Dr. Patel received a total of $14,389 from 98 companies across 814 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Patel's costs compare to other internal medicine physicians in Texarkana?
Dr. Patel's average Medicare payment per service is $71. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Patel) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →